소장자료

>>
소장자료
>
000 cam a
001 2210080755341
005 20130220134556
007 ta
008 130220s2012 nyu b 001 0 eng
010 a 2011024678
020 a9780199734948 (pbk.)
035 a(KERIS)REF000016385100
040 aDLCcDLCdDLCd221008
042 apcc
043 an-us---
050 aKF8925.P7bH47 2012
082 a346.7303/8222
084 aLAW000000aLAW064000aLAW0930002bisacsh
100 aHerrmann, Mark.
245 00 aDrug and device product liability litigation strategy /cMark Herrmann, David B. Alden.
260 aNew York :bOxford University Press, USA,cc2012.
300 axi, 524 p. ;c24 cm.
504 aIncludes bibliographical references and index.
505 aMachine generated contents note: -- Acknowledgments -- 1. Introduction -- 2. The FDA's Regulation of Prescription Drugs and Devices -- 3. Pre-litigation Counseling -- 4. Legal Issues & Theories -- 5. Consolidated Proceedings -- 6. Aggregated Proceedings - Class Actions -- 7. Aggregated Proceedings - Multidistrict Litigation -- 8. Fact Discovery -- 9. Expert Retention and Discovery -- 10. Expert Testimony, Rule 702, And Daubert -- 11. Preemption -- 12. The Learned Intermediary Doctrine -- 13. Motions In Limine -- 14. Jury Selection -- 15. The Trial Of A Drug Or Device Case -- Table of Authorities -- Index.
520 a"Each year, thousands of lawsuits are filed in federal and state courts seeking recovery from manufacturers of pharmaceuticals and medical devices. These lawsuits include individual actions, actions consolidated into multidistrict litigation, and class actions. The litigation occasionally becomes life-threatening for the defendant corporations, and may breed a public relations nightmare, as occurred with Vioxx, breast implants, and fen-phen. Drug & Device Product Liability Litigation Strategy, by Mark Herrmann and David B. Alden, offers assistance to lawyers who practice in this high-stakes, high-profile, and rapidly-evolving area. The book's primary focus is to provide useful practice pointers and overall strategic guidance for attorneys involved in product liability litigation for prescription drugs and medical devices. It will serve as an indispensable guide to handling such a case from pre-litigation through trial. The legal landscape in this important area is expected to shift as the Supreme Court's decisions in Riegel v. Medtronic, Inc. and Wyeth v. Levine are applied, and as the President and Congress address tort reform and other health care issues. Practitioners will need thoughtful, expert advice to navigate these changes"--cProvided by publisher.
650 aProducts liabilityxMedical instruments and apparatuszUnited StatesxTrial practice.
650 aProducts liabilityxDrugszUnited StatesxTrial practice.
650 aLAW / General.2bisacsh
650 aLAW / Litigation.2bisacsh
650 aLAW / Medical Law & Legislation.2bisacsh
700 1 aAlden, David B.
950 0 bUSD250.00
Drug and device product liability litigation strategy
종류
단행본 서양서
서명
Drug and device product liability litigation strategy
발행사항
New York : Oxford University Press, USA c2012.
형태사항
xi, 524 p ; 24 cm.
주기사항
Includes bibliographical references and index. / "Each year, thousands of lawsuits are filed in federal and state courts seeking recovery from manufacturers of pharmaceuticals and medical devices. These lawsuits include individual actions, actions consolidated into multidistrict litigation, and class actions. The litigation occasionally becomes life-threatening for the defendant corporations, and may breed a public relations nightmare, as occurred with Vioxx, breast implants, and fen-phen. Drug & Device Product Liability Litigation Strategy, by Mark Herrmann and David B. Alden, offers assistance to lawyers who practice in this high-stakes, high-profile, and rapidly-evolving area. The book's primary focus is to provide useful practice pointers and overall strategic guidance for attorneys involved in product liability litigation for prescription drugs and medical devices. It will serve as an indispensable guide to handling such a case from pre-litigation through trial. The legal landscape in this important area is expected to shift as the Supreme Court's decisions in Riegel v. Medtronic, Inc. and Wyeth v. Levine are applied, and as the President and Congress address tort reform and other health care issues. Practitioners will need thoughtful, expert advice to navigate these changes"

소장정보

청구기호 : 346.73038 H469D
도서예약
서가부재도서 신고
보존서고신청
캠퍼스대출
우선정리신청
검색지인쇄
등록번호 청구기호 별치기호 소장위치 대출상태 반납예정일 서비스
등록번호
W0119204
청구기호
346.73038 H469D
별치기호
소장위치
법학도서분관(부민)
대출상태
대출가능
반납예정일
서비스
서가부재도서 신고
캠퍼스대출

책소개

전체 메뉴 보기